A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,875

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Myocardial InfarctionSegment Elevation Myocardial Infarction (STEMI)
Interventions
DRUG

Ticagrelor

Oral Ticagrelor loading dose (180 mg) followed by matching placebo

DRUG

Placebo

Placebo followed by oral Ticagrelor loading dose (180 mg)

Trial Locations (96)

Unknown

Research Site, Algiers

Research Site, Blida

Research Site, Herston

Research Site, Southport

Research Site, Woolloongabba

Research Site, Graz

Research Site, Innsbruck

Research Site, Vienna

Research Site, Halifax

Research Site, Newmarket

Research Site, Scarborough Village

Research Site, Regina

Research Site, Aalborg

Research Site, Aarhus

Research Site, Odense C

Research Site, Aubervilliers

Research Site, Besançon

Research Site, Boulogne-Billancourt

Research Site, Bourges

Research Site, Bron

Research Site, Châteauroux

Research Site, Corbeil-Essonnes

Research Site, Créteil

Research Site, Dijon

Research Site, Lagny-sur-Marne

Research Site, Le Chesnay

Research Site, Le Coudray

Research Site, Lyon

Research Site, Marseille

Research Site, Massy

Research Site, Melun

Research Site, Montauban

Research Site, Montfermeil

Research Site, Montreuil

Research Site, Neuilly-sur-Seine

Research Site, Nîmes

Research Site, Paris

Research Site, Pessac

Research Site, Quincy-sous-Sénart

Research Site, Rouen

Research Site, Strasbourg

Research Site, Tours

Research Site, Vannes

Research Site, Bad Friedrichshall

Research Site, Bad Nauheim

Research Site, Darmstadt

Research Site, Esslingen am Neckar

Research Site, Freiburg im Breisgau

Research Site, Giessen

Research Site, Hanover

Research Site, Ludwigshafen

Research Site, Lüdenscheid

Research Site, Mainz

Research Site, Merseburg

Research Site, Wuppertal

Research Site, Budapest

Research Site, Debrecen

Research Site, Pécs

Research Site, Szeged

Research Site, Arezzo

Research Site, Ascoli Piceno

Research Site, Cona

Research Site, Forlì

Research Site, Genova

Research Site, Grosseto

Research Site, Massa

Research Site, Seriate

Research Site, Siena

Research Site, 's-Hertogenbosch

Research Site, Alkmaar

Research Site, Arnhem

Research Site, Terneuzen

Research Site, A Coruña

Research Site, Alicante

Research Site, Badalona

Research Site, Barcelona

Research Site, Hospitalet de Llobregat(Barcel

Research Site, Madrid

Research Site, Málaga

Research Site, Santiago(A Coruña)

Research Site, Seville

Research Site, Vigo(Pontevedra)

Research Site, Gävle

Research Site, Linköping

Research Site, Örebro

Research Site, Uppsala

Research Site, Ashford

Research Site, Belfast

Research Site, Cambridge

Research Site, Coventry

Research Site, Eastbourne

Research Site, Hastings

Research Site, Middlesbrough

Research Site, Newcastle upon Tyne

Research Site, Norwich

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY